Lee Ainslie Johnson & Johnson Transaction History

Maverick Capital LTD

$4.82 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $2.69 Million - $3.01 Million	-17,240 Reduced 73.93%	6,080 $946,000
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $2.7 Million - $2.9 Million	17,462 Added 298.09%	23,320 $3.86 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $966,417 - $1.15 Million	-6,398 Reduced 52.2%	5,858 $907,000
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $688,699 - $772,917	4,299 Added 54.03%	12,256 $2.17 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $303,623 - $337,856	1,882 Added 30.98%	7,957 $1.3 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $16,146 - $17,856	96 Added 1.61%	6,075 $1.08 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $945,519 - $1.07 Million	5,979 New	5,979 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $5.8 Million - $6.43 Million	-37,191 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $1.55 Million - $1.72 Million	-9,596 Reduced 20.51%	37,191 $6.01 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $7.46 Million - $8 Million	46,787 New	46,787 $7.71 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $5.7 Million - $6.88 Million	-44,249 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $3.61 Million - $5 Million	-32,451 Reduced 42.31%	44,249 $5.8 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.39 Million - $1.6 Million	-10,903 Reduced 12.45%	76,700 $11.2 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $2.33 Million - $2.61 Million	18,363 Added 26.52%	87,603 $11.3 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $1.21 Million - $1.33 Million	9,220 Added 15.36%	69,240 $9.64 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $5.64 Million - $6.27 Million	44,840 Added 295.39%	60,020 $8.39 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $4.76 Million - $5.73 Million	-38,770 Reduced 71.86%	15,180 $1.96 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $2.42 Million - $2.84 Million	-19,870 Reduced 26.92%	53,950 $7.45 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $2.99 Million - $3.29 Million	-25,000 Reduced 25.3%	73,820 $8.96 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $3.92 Million - $4.64 Million	31,300 Added 46.36%	98,820 $12.7 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $3.62 Million - $3.97 Million	27,620 Added 69.22%	67,520 $9.43 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $5.17 Million - $5.4 Million	39,900	39,900 $5.19 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Lee Ainslie's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Account